About the Company
We do not have any company description for Biohaven Ltd. at the moment.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BHVN News
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, ...
Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)
Director Gregory Bailey has recently increased his stake in Biohaven Ltd (NYSE:BHVN) by purchasing 48,780 shares of the ...
Biohaven Prices Offering Of $230 Mln Of Shares At $41/share; Stock Down In Pre-Market
Biohaven Ltd. (BHVN) on Thursday announced the pricing of its underwritten public offering of 5,609,757 shares at $41 per share for ...
Biohaven Stock (NYSE:BHVN), Analyst Ratings, Price Targets, Predictions
There is no last upgrade for Biohaven.
Buy Rating Affirmed for Biohaven Ltd. Amid Positive Clinical Outlook and Pipeline Potential
J.P. Morgan analyst Tessa Romero has maintained their bullish stance on BHVN stock, giving a Buy rating yesterday. Tessa Romero has given his ...
Biohaven Announces Pricing of $230 Million Public Offering of Common Shares
NEW HAVEN, Conn., April 18, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments ...
Biohaven Announces Proposed Public Offering of Common Shares
NEW HAVEN, Conn., April 17, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key ...
Bullish Biohaven Insiders Loaded Up On US$23.8m Of Stock
In the last year, multiple insiders have substantially increased their holdings of Biohaven Ltd. ( NYSE:BHVN ) ...
Biohaven Ltd BHVN
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Biohaven Ltd.: Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
NEW HAVEN, Conn., Feb. 29, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and ...
Loading the latest forecasts...